Innovation Pharmaceuticals signs drug product manufacturing contract with CoreRx
Innovation Pharmaceuticals reports it has signed a Drug Product manufacturing contract with CoreRx, a leading CDMO, for formulating Brilacidin into granular form in unit dose sachets. Such drug product packaging in the form of sachets provides patients with a convenient, and portable rinse therapy. July 17, 2018